05. December. 2024
The end-of-year meeting of the CNATM network took place at the beginning of December. Here, the cluster partners from academia and industry had the opportunity to continue exchanging ideas, further consolidate collaborations and create new perspectives.
12. November. 2024
We welcome Prof. Peter M. Tessier to the Ludwig-Maximilian-University München for a seminar on the topic “Precision Gene Silencing in the Central Nervous System”.
Peter M. Tessier is Professor of Pharmaceutical Sciences and Chemical Engineering at the University of Michigan. His research goal is to develop first-in-class therapeutic antibodies and apply them to solve many important biomedical challenges. In his talk, he will present his work on antibody-nucleic acid conjugates that penetrate the blood-brain barrier.
Chair: Prof. Olivia Merkel, Cospeaker of CNATM
When? November 12, 2024 at 5 pm
Location? ICEM, LMU, Würmtalstr. 201, 81375 München
Registration at info@cas.lmu.de is required for participation.
Ein weiteres Seminar findet im BNMRZ statt zum Thema :“Investigating structural dynamics and binding interactions of intrinsically disordered proteins by NMR spectroscopy: New insights into the pre-fusion state of SNARE proteins“ von Dr. Nils Lakomek (Universität Düsseldorf).
Who? Wednesday, Nov 6, 2024, 1:30 pm
Location? BNMRZ Seminar Room, TUM, Garching
Ein weiteres Seminar findet im BNMRZ statt zum Thema :“Integrative Modelling for the Characterisation of the Structure and Dynamics of Biomolecules“ von Dr. Federico Ballabio (Fakultät für Biowissenschaften, Università degli Studi di Milano, Italy)
When? Friday, Sep 13, 2024, 1:30 pm
Location? BNMRZ Seminar Room, TUM, Garching
24. September. 2024
We welcome Prof. Kenneth R. Chien to the Clinic and Polyclinic for Internal Medicine I of the TUM University Hospital rechts der Isar, who will speak on the topic “An Entrepreneurial Guide to the mRNA Universe”.
Prof. Chien (*1951) is an internationally renowned scientist in the field of cardiovascular research, with particular success in regenerative cardiovascular medicine. He developed new therapeutic approaches for the treatment of heart insufficiency. During his scientific career, he has held numerous leadership positions, including at the UC San Diego-Salk Institute, Massachusetts General Hospital and the Karolinska Institute.
Prof. Chien has a fundamental interest in the translation of new drugs. He is a co-founder of Moderna Therapeutics and an indispensable consultant to numerous biotech and big pharma companies (including Roche and Pfizer). His wealth of experience in bringing new active ingredients to the clinic for practical application is in demand in the biotech and pharmaceutical industry.
In addition, we would like to draw your attention to the offer for young scientists, a panel discussion with Prof. Kenneth R. Chien and Dr. Marijn E. Dekkers, former Bayer AG CEO.
When? September 24, 2024 at 10 am
Location? Lecture Hall A, Klinikum rechts der Isar
CNATM will be a part of the 1st Munich Postdoc Night this fall. Don’t miss the opportunity to network with key players in Munich, listen to interesting keynote speeches and a poster session.
Where & when?
Thursday, Sept 12th, from 5-9 pm, at the Bavarian Academy of Sciences and Humanities (BAdW) at Odeonsplatz
Joint symposium by CNATM, SFB1309 and Center of Advanced Study (CAS): guest speaker Benjamin List (Nobel prize 2021) in chemistry.
Continue reading
10. July 2024
Location? MPI of BIochemistry, T-Building, Small Lecture Hall
Splicing activator RNPS1: Functions in the PSAP-dependent and -independent manner
03. Juni 2024, 14:00 Uhr
Prof. Akila Mayeda(Fujita Health University, Toyoake, Japan) will give a lecture on ‘Splicing activator RNPS1: Functions in the PSAP-dependent and -independent manner’.
Location: Bavarian NMR Center, Seminar Room, Department of Bioscience, TUM School of Natural Sciences, Garching
Developing mRNA based Therapeutics
Over the past years mRNA based therapeutics moved into the focus of drug development. With mRNA based vaccines in the market now the field is looking towards broader application of the technology. As a pioneer in the field CureVac has discovered several main principles that are relevant in development. The presentation discusses different applications of mRNA in drug development.
Patrick Baumhof is Senior Vice President of Technology at CureVac (Tübingen)
Location: ICEM / House L, Seminarraum, Würmtalstr. 201, 81377 Munich
Registration by e-mail is required for participation
